1,642
Participants
Start Date
December 11, 2024
Primary Completion Date
December 31, 2028
Study Completion Date
June 30, 2029
Biopsy strategy
Number of random biopsies, in addition to targeted biopsies, taken during colonoscopies where at least one indication for the colonoscopy is surveillance for dysplasia
NYU Langone Health, New York
University of Rochester, Rochester
Allegheny Health Network, Pittsburgh
University of Pennsylvania, Philadelphia
Mercy Medical Center, Baltimore
University of North Carolina, Chapel Hill
Mayo Clinic Jacksonville, Jacksonville
AdventHealth, Orlando
University of Alabama Birmingham, Birmingham
Mayo Clinic Rochester, Rochester
University of Colorado, Aurora
University of Utah, Salt Lake City
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Abramson Cancer Center at Penn Medicine
OTHER